This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SLIM Obesity ETF (SLIM) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Obesity ETF (NASDAQ:SLIM) 30 days 90 days 365 days Advanced Chart Get Obesity ETF alerts:Sign Up Key Stats Today's Range$33.17▼$33.1750-Day Range$33.17▼$33.1752-Week Range$31.59▼$43.40VolumeN/AAverage Volume4,086 shsMarket Capitalization$9.95 millionAssets Under Management$13.68 millionDividend Yield0.66%Net Expense Ratio0.50%Aggregate RatingN/A ETF OverviewRead More… Obesity ETF ExpensesTypeSLIMHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.57%0.57%0.54%0.54%Other Expenses0.00%0.30%0.48%0.42%0.51%Total Expense0.50%0.70%0.72%0.69%0.71%Fee Waiver0.00%-0.45%-0.48%-0.29%-0.54%Net Expense0.50%0.60%0.63%0.62%0.60% Receive SLIM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Obesity ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address SLIM ETF News HeadlinesEli Lilly: Obesity Drug Development To Go Beyond That Of ZepboundMay 16, 2025 | seekingalpha.comThe slim get slimmer, the heavy wait: Obesity drug divide growsApril 30, 2025 | msn.comTrump’s Manhattan ProjectThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washington… even Trump’s obsession with seizing Greenland. There’s a singular force that connects the dots… And it could threaten to transform American life – and your wealth – forever. June 14, 2025 | Porter & Company (Ad)Rhythm: Late-Stage Study Win Brings About Change For Rare Obesity DisorderApril 8, 2025 | seekingalpha.com​Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment​ (Rating Downgrade)March 11, 2025 | seekingalpha.comMissing protein keeps mice slim on high-fat dietFebruary 27, 2025 | msn.comSee More Headlines SLIM ETF - Frequently Asked Questions What other stocks do shareholders of Obesity ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Obesity ETF investors own include ServiceNow (NOW), SolarEdge Technologies (SEDG), Supernus Pharmaceuticals (SUPN), Teva Pharmaceutical Industries (TEVA), Galmed Pharmaceuticals (GLMD), Infosys (INFY) and Nightstar Therapeutics (NITE). Fund Details IssuerJanus Henderson Fund NameThe Obesity ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:SLIM Inception Date6/8/2016 Fund ManagerBenjamin Wang, Scott M. Weiner WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkSolactive Obesity Index CategorySector FocusHealth Care Development LevelBlended Development RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$13.68 million Average Daily Volume$2.33 thousand Discount/Premium-0.38% Administrator, Advisor and Custodian AdministratorJanus Capital Management LLC AdvisorJanus Capital Management LLC CustodianState Street Bank and Trust Company DistributorALPS Distributors, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares300,000BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report SLIM Sector ExposureSLIM Industry Exposure This page (NASDAQ:SLIM) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Obesity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Obesity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
